Introduction
FHIT (fragile histidine triad gene), a candidate tumor suppressor gene, was recently identi®ed at chromosome 3p14.2 . FHIT is located within the fragile site, FRA3B. Fragile sites are prone to develop gaps in the genome when exposed to speci®c toxic reagents (Sutherland, 1991) ; these gaps may allow for chromosomal rearrangement or even chromosomal deletion during the process of tumorigenesis (Yunis and Soreng, 1984) . Interestingly, the FRA3B site is cytogenetically indistinguishable from the area of chromosomal translocation (t(3;8)(p14.2;q24)) responsible for the heritable form of renal cell carcinoma. Furthermore, numerous studies have demonstrated that chromosome 3p allelic losses in the region of the FRA3B/ FHIT site occur in many forms of cancer (Naylor et al., 1987; Brauch et al., 1987; Zbar et al., 1987; Mooibroek et al., 1987; Zeiger et al., 1995; Kastury et al., 1996) . Representational dierence analysis demonstrated a frequent site of homozygous deletion at the FHIT locus in esophageal, gastric and colorectal carcinomas (Lisitsyn et al., 1994) . Several recent papers have reported alterations of FHIT in several tumor types, frequently characterized by abnormal-sized transcripts (Virgilio et al., 1996; Sozzi et al., 1996; Yanagisawa et al., 1996; Mao et al., 1996; Ohta et al., 1996; Druck et al., 1997) . However, some investigators have found a completely normal FHIT transcript and coding DNA sequence in colorectal carcinoma cell lines and xenografts, suggesting either a dierent inactivation mechanism or a minor role for FHIT in the genesis of colorectal cancer (Thiagalingam et al., 1996) . Therefore, in order to further evaluate the involvement of FHIT in certain gastrointestinal tumors, we investigated 63 primary esophageal carcinomas, nine esophageal cancer cell lines, and 17 ulcerative colitis-associated neoplasms (UCANs) for alterations of FHIT. Thirteen primary esophageal tumors, nine esophageal cell lines, and 17 UCANs were evaluated for abnormal FHIT gene transcript size as well as point mutations in the FHIT open reading frame (ORF). Fifty additional esophageal cancers were tested for loss of heterozygosity (LOH) aecting the FHIT locus at 3p14.2. Finally, 11 of these 50 tumors, which showed LOH at the FHIT locus, were also studied for subtle ORF point mutations by exon-speci®c genomic DNA PCR and sequencing.
Results and Discussion

Loss of heterozygosity analysis in 50 primary esophageal tumors
To investigate whether allelic loss was frequent at the FHIT locus, a PCR-based approach was performed utilizing primers that amplify two polymorphic microsatellite markers internal to and¯anking the FHIT gene . The microsatellite marker D3S1300 is located in intron 5 of the FHIT gene, while marker D3S1313 is slightly telomeric to FHIT. Among a separate group of 50 primary esophageal cancers, 11 demonstrated LOH of D2S1300, D3S1313, or both markers. The results included 27 informative cases at D3S1300, of which eight (30%) demonstrated LOH; and of 19 cases informative at D3S1313, 7 (37%) exhibited LOH. Four of these cases demonstrated LOH involving both allelic markers. Examples are shown in Figure 1 .
Exon-speci®c PCR and sequencing of genomic DNAs in esophageal cancers and cell lines
In order to determine whether point mutations within the remaining allele of FHIT were present in primary esophageal tumors showing LOH at 3p14.2, exonspeci®c sequencing of genomic DNA was performed (these tumors did not have RNA available). Separate primer sets based on published intron-exon boundary sequences were synthesized for each FHIT exon 5, 6, 7, 8 and 9 (Ohta et al., 1996) . These genomic DNA-based PCRs were successfully carried out in 11 primary esophageal tumors that had previously demonstrated LOH of either D3S1300 or D3S1313. Additionally, an identical genomic PCR-based analysis was performed on DNAs from the nine esophageal cancer cell lines. Among the 11 primary esophageal tumors showing LOH, two contained the same silent nucleotide substitution in exon 7, consisting of C to T transitions at nucleotide 626 (GCC ± GCT), codon 88 (alanine). This apparent polymorphism has been described by other investigators (Mao et al., 1996) . Additionally three primary tumors demonstrated A to G transitions within intron 6. This transition occurred 32 base pairs from the exon 6-intron 6 boundary; it most likely also represents a polymorphism. Among the nine esophageal cancer cell lines investigated by exon-speci®c sequencing, four contained an identical silent substitution within exon 8, consisting of a T to C transition at nucleotide 656 (CAT ± CAC), codon 98 (histidine). This probable polymorphism has also been reported previously (Mao et al., 1996) . An example is shown in Figure 2 .
RT ± PCR in primary esophageal cancer, esophageal cancer cell lines and UCANs RT-PCR was used to detect aberrant or absent FHIT transcripts in 17 UCANs, 13 primary esophageal cancers, and nine esophageal cancer-derived cell lines. RNA was isolated, reverse transcribed to cDNA, and PCR-ampli®ed using primers P1/1R (exons 5 ± 6) and P2/2R (exons 6 ± 9) of the FHIT gene (see Materials and methods; see also Figure 3 ). In all 17 UCANs and in 12 of the 13 esophageal cancers from which RNA was available, a normal-sized RT ± PCR product was generated with both primer sets, corresponding to the wild-type open reading frame of FHIT; however, one esophageal cancer, sample E224T, yielded no RT ± PCR product with either primer pair. Additionally, the FHIT RT ± PCR product was only ampli®able from cell lines EC50, EC110, and EC350. Exactly similar results were obtained using both primers P1f/P1r and P2f/P2r. The remaining six esophageal cell lines yielded no detectable RT ± PCR products with either primer
Loss of heterozygosity at microsatellite loci D3S1300 and D3S1313 in primary esophageal carcinomas. N, normal tissue DNA; T, tumor DNA. Sample JE6, LOH aecting locus D3S1300; samples JE12, E100 and E364, LOH at marker D3S1313. Normal lanes (N) demonstrate two alleles of equal intensity; tumor lanes show a shift in intensity to one dominant allele
F igure 2 DNA sequencing of FHIT exon 8 in esophageal cancer cell lines EC50 and EC520. EC520 shows a T to C transition at nucleotide 656 (codon 98), representing a previously reported polymorphism at this location (Mao et al., 1996) . EC50 demonstrates the known wild-type sequence at this same location Figure 3 Open reading frame of FHIT and primers used to amplify it (exons 5 to 9). The position and nucleotide numbers of splice site are shown by downward arrows, and the start codon and stop codons are shown by upward arrows. PCR #1 primers P1f and P1r spanned at 243 ± 597; PCR #2 spanned at 583 ± 870. The overlapping primer sets thus ampli®ed the entire open reading frame of FHIT set, although b-actin was easily detectable in all nine cell lines (Table 1 ; examples, Figure 4 ).
cDNA sequence analysis
The complete open reading frame sequence of FHIT, spanning exons 5 ± 9, was determined from RNA obtained from 17 UCANs and 13 of the primary esophageal cancers (see Materials and methods and Figure 3 ). In the 17 UCANs and in 12 of the 13 esophageal cancers, this entire coding sequence was wild-type. In one esophageal cancer sample (E224T), no RT ± PCR product was ampli®able using either of the two primer sets (data summarized in Table 2 ). ISVP RT ± PCR followed by transcription/translation was successfully performed on RNAs from all 17 UCANs, as described (Powell et al., 1993) . Both tumor and matching normal RNAs from all 17 UCANs yielded a single band corresponding to the full-length wild-type FHIT protein (approximately 20 kDa). No bands representing truncated (mutant) proteins were observed in any of the UCAN specimens ( Figure 5 ).
Inactivation of tumor suppressor genes may occur in either of two ways (Knudson, 1993) : its expression may be quantitatively altered, or the protein encoded by the gene may be qualitatively altered by missense or nonsense mutations. We based our methodologic approach on these two mechanisms of inactivation. In order to determine whether FHIT mRNA expression was altered, we ampli®ed exons 5 ± 9 of the FHIT gene using RT ± PCR of RNA from 13 primary esophageal tumors, nine esophageal cancer cell lines, and 17 UCANs. Exons 5 ± 9 contain the entire open reading frame of FHIT; moreover, all previously documented alterations of FHIT have involved at least on of the ®ve exons. However, we found very few alterations in the expression of FHIT when comparing normal and tumor RNA obtained from primary esophageal cancers of UCANs: only one primary esophageal tumor expressed no detectable FHIT transcript. We did not detect any alternatively spliced or truncated transcripts of FHIT. However, RT ± PCR generated a product from only three of nine esophageal cell lines studied. Further investigation by exon-speci®c sequencing of genomic DNA demonstrated only one of these six nonexpressing cell lines to be lacking exon 5; the remaining ®ve cell lines contained a completely normal genomic sequence of FHIT exons 5 ± 9, including splice donor and acceptor sites in adjoining introns. These results are consistent with the essentially negative data of some other investigators in primary colon cancers (Thiagalingam et al., 1996) . These authors studied 29 colon cancer cell lines and xenografts by sequencing the entire open reading frame of FHIT: no alterations were found within the open reading frame of this gene (ibid.). These ®ndings suggest that FHIT may not be causally related to gastrointestinal carcinogenesis in the colon or esophagus, but rather may be located adjacent to a second tumor suppressor gene on chromosome 3p14. Frequent allelic loss of homozygous deletion of a chromosomal region suggests the presence of a tumor suppressor gene. Previous studies (Sozzi et al., 1996; Kastury et al., 1996; Zeiger et al., 1994) have demonstrated LOH and homozygous deletion in the region surrounding FHIT. We found LOH in 37% of our informative cases; however, among 11 cases demonstrating LOH, genomic DNA sequencing of the entire FHIT open reading frame delineated only silent nucleotide substitutions in exon 7 in two cases and intronic substitutions in three cases. We also found silent substitutions in exon 8 in four cell lines. Similar substitutions in exons 7 and 8 have been reported in head and neck squamous cell carcinoma cell lines (Mao et al., 1996) . These nucleotide substitutions should not alter FHIT protein structure or function. Therefore, mutation of FHIT does not appear to accompany LOH in primary esophageal tumors: this ®nding does not ®t the paradigm for a tumor suppressor gene. Nevertheless, the relatively high rate of LOH at chromosome 3p14 in esophageal tumors suggests the presence of an additional tumor suppressor gene at this locus; this possibility remains to be investigated.
Materials and methods
Tissue samples and cell lines
Matching normal and tumor tissues were obtained at the time of surgical resection or endoscopic biopsy. All tissues were obtained fresh, grossly dissected free of normal surrounding tissues, and immediately frozen in liquid nitrogen. Esophageal tumors were collected from the University of Maryland or Veterans Aairs Hospitals in Baltimore, while UCANs were from Mt Sinai Hospital, New York. Trizol Reagent (GIBCO/BRL, Gaithersburg, MD) was used for both DNA and RNA preparation, as described (Rhyu et al., 1994) . Esophageal cancer cell lines were derived by Dr Yutaka Shimada, Kyoto University.
Reverse transcriptase-PCR (RT ± PCR) and cDNA sequencing
Total RNA was available and extracted from 13 primary esophageal carcinomas and nine esophageal carcinoma cell lines, as well as 17 UCANs and their corresponding normals. cDNA was synthesized from 5 mg of total RNA. RT was performed in a 20 ml volume of 16 ®rst strand buer (GIBCO-BRL), 10 mM DTT, 500 mM of dNTPs, 15 mg/ml oligo (dT) primers, and 200 units of SuperScript II reverse transcriptase. The samples were ®rst denatured for 10 min at 708C, then incubated at 428C for 50 min. Two ml of cDNA were used for each PCR ampli®cation with primers P1f/1r (sense: 5'-GAGAAAGAAGGTATCC-TAGG-3'; antisense: 5'-TGAGAGAGGTCCCATGGAAA-3') and P2f/2r (sense: 5'-ATGGGACCTCTCTCACCTTT-3'; antisense: 5'-GCGGTCTTCAAACTGGTTGG-3') spanning exons 5 ± 9 of FHIT. PCR conditions consisted of an initial denaturation step at 958C for 5 min followed by 33 cycles of 60 s at 948C, 60 s at 508C and 2 min at 728C, then followed by a ®nal extension of 5 min at 728C.
Each ampli®ed DNA fragment was directly sequenced on both strands using a PCR product direct sequencing kit (USB) with primers internal to P1f/1r and 2f/2r (S1, 5'-GAGGACTCCGAAGAGGTAGC-3' and S2r, 5'-GCAA-TAGCTCTTTTGCTG-3'). A schematic diagram of the primers used in these PCRs is provided in Figure 3 .
As an internal control for RNA integrity and quantity, bactin was ampli®ed in separate PCR reactions, as well as in duplex PCRs concurrently with FHIT, as described (Zhou et al., 1995) . Primers used for b-actin ampli®cation were 5'-CCAGAGCAAGAGAGGCATCC-3' (forward) and 5'-CCGTGGTGGTGAAGCTGTAG-3' (forward). Examples of these PCRs are shown in Figure 4 .
Loss of heterozygosity analysis
LOH analysis was performed using a PCR-based approach with primers amplifying polymorphic microsatellite alleles at loci D3S1300 and D3S1313 . Genomic DNAs from primary tumor and corresponding normal tissues of 50 esophageal cancer patients were analysed. Template genomic DNA (50 ng) was ampli®ed in a 10 ml reaction containing 0.2 mCi of [ 32 P]dCTP in the ampli®cation mixture for 33 cycles. PCR products were separated by electrophoresis at 100 W for 5 h on 6% denaturing polyacrylamide gels and visualized by autoradiography. For informative cases, allelic loss was scored if the autoradiographic signal of one allele was at least 50% reduced in tumor DNA compared to matching normal DNA. Loci displaying microsatellite instability were not scored for allelic loss. Examples are shown in Figure 1 .
Exon-speci®c PCR ampli®cation and sequencing of genomic DNAs
Exon-speci®c PCR ampli®cation was carried out using genomic DNAs from 11 primary esophageal tumors that showed LOH on chromosome 3p14.1, as well as in all nine esophageal cancer cell lines. The following primer pairs were used: Exon 1: UR4 (sense), CTGCTCTGTCCGGTC-ACA and I15'R (antisense), GTCGGTGCTTGGGAAT-TG; Exon 2: iex2f (sense), AGGTACGAGGCACAAGTT and iex2R (antisense), GCAGGTGGTTAAGGAAGT; Exon 3: iex3F (sense), AGGGTGATACTAGCTGCTTT and iex3R (antisense), TGACTTTAGCCAGTGGCA; Exon 4: iex4F (sense), TTGTACCTAGAGCCATCTGG and iex4R (antisense), GGATACTCACAGCAGGTCAA; Exon 5: iex5F (sense), ATGGCATCCTCTCTGCAA and iex5R (antisense), TTCATTTGGCTGGTTAGG; Exon 6; iex6F (sense), GGTCCGAGAGGATTCAAT and iex6R (antisense), TATCAGGAGGAGCAAGCC; Exon 7: iex7F (sense), TGGTCCCCATGAGAATACTA and iex7R (antisense), TTACGGCTCTAACACTGAGG; Exon 8: iex8F (sense), GGAGTAATTGGGCTTCAT and iex8R (antisense), AGGTTGATGTCATCCCAC; Exon 9: iex9F (sense), TTCAAGGAGATCCCAAGG and iex9R (antisense), TGTGCATCCCCATTCTGA. PCR ampli®cation consisted of 30 cycles at 948C for 0.5 min, 578C for 0.5 min and 728C for 0.5 min after an initial denaturation step (958C for 5 min). PCR products were directly sequenced using the same primers as those used for PCR (Meltzer et al., 1990) . Examples are shown in Figure 2 .
In vitro synthesized protein assay (IVSP)
The entire open reading frame of FHIT, encompassing nucleotides 363 to 806, was analysed using the IVSP assay (Powell et al., 1993) . Primers for FHIT gene ampli®cation were 5'-[T7-trans-]-CCTTGCAACGTTAGCTGTTG-3' and 5'-CCTCAGTCTAAAGGTTGTGG-3'. The T7-trans motif, which contains the Kozak translation and T7 DNA polymerase consensus, is 5'-GGATCCTAATACGACT-CACTATAGGGAGACCACCATGG-3' (ibid.). FHIT was ampli®ed under the following conditions: denaturation at 958C for 1.5 min, then annealing at 588C for 35 cycles. Based on concentrations of PCR products, 5 to 10 ml of each PCR reaction were directly added to coupled Proteins were analysed as previously described . Examples are shown in Figure 5 .
